Nune Eye Hospital, Seoul, Korea Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2015
NCT03475407
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Nune Eye Hospital | Nune Eye Hospital, Seoul, Korea

Active Ingredients

Drugs in Phase 4 Trials (2)

aflibercept (zaltrap) (1 trial)

dexamethasone (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Macular Edema (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2